Psoriasis is a chronic skin disease with a prevalence of 2-3% in the population and progresses with attacks. However, its coexistence with many systemic diseases has been noticed in recent years. Obesity, diabetes, hypertension, hyperlipidemia, metabolic syndrome, nonalcoholic fatty liver disease, inflammatory bowel disease and cancer rates have been found to be higher in psoriasis patients than in the general population.
Psoriasis can present in many different ways. The most commonly seen plaque type is characterized by red skin areas covered by pearl-colored desquamation. The condition can lead to deformities and pain with nail and joint involvement. According to recent data, there are approximately 1 million psoriasis patients in Turkey. Genetic susceptibility is an important factor in psoriasis as it is not contagious. However, the triggering effects of the immune system and environmental factors are quite important in the onset and attacks of the disease. Psoriasis usually starts when the patient is in his/her 20s and stress is an important trigger.
The diagnosis is often made with the clinical findings. If making the diagnosis is difficult, a small biopsy is taken from the skin to confirm the diagnosis.
The treatment is determined according to the extent of disease, age, accompanying nail and/or joint involvement, and the compliance of the patient with the treatment. After evaluating these factors, the dermatologist will decide on topical (local), light (ultraviolet), and conventional systemic or biological treatments as appropriate for the person. There are many current studies on psoriasis. Treatment success has increased greatly with new drugs. However, the compliance of psoriasis patients with treatment is an integral part of the treatment process.